Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

<< < Results 181 - 190 of 209 > >>
download as CSV
download all results as CSV
EC Number Inhibitors Commentary Structure
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21YM-53601 - Go to the Ligand Summary Page
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21zaragozic acid IC50 0.7 nM Go to the Ligand Summary Page
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21zaragozic acid competitive to farnesyl diphosphate Go to the Ligand Summary Page
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21zaragozic acid hypolipidemic effects but potential toxicity because of high levels of urinary dicarboxylic acid Go to the Ligand Summary Page
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21zaragozic acid - Go to the Ligand Summary Page
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21zaragozic acid decrease in plasma cholesterol Go to the Ligand Summary Page
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21zaragozic acid competitive type of inhibition Go to the Ligand Summary Page
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21zaragozic acid potent inhibitor Go to the Ligand Summary Page
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21zaragozic acid A 0.04 mM Go to the Ligand Summary Page
Show all pathways known for 2.5.1.21Display the word mapDisplay the reaction diagram Show all sequences 2.5.1.21zaragozic acid A inhibition of squalene synthase. Administration also significantly increases the rate of degradation of hepatic low density lipoprotein receptor protein, and increases proprotein convertase subtilisin/kexin type 9 mRNA and protein levels in concert with an increase in hepatic low density lipoprotein receptor mRNA levels, low density lipoprotein turnover, and decreases in serum cholesterol levels Go to the Ligand Summary Page
<< < Results 181 - 190 of 209 > >>
download as CSV
download all results as CSV